For Your Kitchen
Cookbooks

Everyday recipes with room for flavor, variety, and real life. Dinner should not feel like homework.

Taste it

Sponsorship complete. Dine on...

Nutrition, wellness, weight loss, and calmer healthy living.

Tirzepatide Linked to 33% Reduction in Heart Attack Risk for Diabetics

Aug 10, 2026
Tirzepatide Linked to 33% Reduction in Heart Attack Risk for Diabetics

The use of glucagon-like peptide-1 (GLP-1) receptor agonist medications is on the rise, prompting researchers to investigate their effects beyond managing type 2 diabetes and aiding weight loss. A new study published in The BMJ has revealed that the GLP-1 medication tirzepatide, which is the active ingredient in Mounjaro and Zepbound, may significantly lower the risk of major cardiovascular events, such as heart attacks and strokes, in individuals with type 2 diabetes and existing heart disease.

In this study, researchers analyzed clinical data from nearly 53,000 participants who had both type 2 diabetes and heart disease. Participants were divided into two groups: one group received tirzepatide, while the other was given sitagliptin, a diabetes medication that does not have cardiovascular benefits. The researchers monitored the incidence of major adverse cardiovascular events (MACE), which include heart attack, stroke, and all-cause mortality.

For Your Kitchen
Cookbooks
Taste it
Kitchen Scales
Taste it
Meal Prep Containers
Taste it

Sponsorship complete. Dine on...

The findings were significant. After one year, the group taking tirzepatide exhibited a MACE risk of 2.9%, compared to 4.4% in the sitagliptin group. This translates to a tangible benefit, with researchers estimating that for every 70 patients treated with tirzepatide, one major cardiovascular event could be prevented.

Nils Krüger, MD, MPH, the lead author of the study and a physician data scientist at Brigham and Women’s Hospital, emphasized the importance of understanding the broader effects of GLP-1 medications. He noted that while these medications were initially designed to improve glucose control, their potential to reduce the incidence of serious cardiovascular events is a critical area of exploration.

Krüger highlighted that cardiovascular disease is a leading cause of morbidity and mortality worldwide, making it essential to evaluate whether GLP-1 medications can effectively mitigate risks associated with heart attacks and strokes.

The study also found that tirzepatide was associated with a 33% lower risk of heart attacks compared to sitagliptin. Krüger explained that this reduction in myocardial infarction is crucial, as heart attacks represent one of the most severe complications related to diabetes and cardiovascular disease.

The mechanisms by which tirzepatide may lower MACE risk are likely multifactorial. Tirzepatide not only improves glucose control and aids in weight loss but may also positively affect blood pressure, lipid levels, inflammation, and other cardiometabolic risk factors. Interestingly, the cardiovascular event curves began to diverge early in the study, suggesting that factors other than weight loss, such as vascular or anti-inflammatory effects, might also play a role.

Looking ahead, Krüger indicated that further research is needed to determine whether these cardiovascular benefits persist over time and can be replicated across different populations and healthcare systems. Additionally, he expressed interest in understanding the underlying mechanisms that contribute to the observed reductions in infection-related events.

Experts in the field, such as Cheng-Han Chen, MD, and Sanjeev Kumar Gulati, MD, have commented on the implications of this study, noting that it adds to the growing body of evidence supporting the cardiometabolic advantages of GLP-1 receptor agonists. They emphasized the need for longer-term studies to confirm these findings and to explore how these medications can optimize patient care across various cardiometabolic conditions.

For Your Kitchen
Cookbooks
Taste it
Kitchen Scales
Taste it
Meal Prep Containers
Taste it
Vegetable Prep & Salad Spinners
Taste it

Sponsorship complete. Dine on...

For Your Kitchen
Cookbooks

Everyday recipes with room for flavor, variety, and real life. Dinner should not feel like homework.

Taste it
Kitchen Scales

Kitchen scales for recipes that deserve more precision than 'that looks about right.'

Taste it
Meal Prep Containers

Give tomorrow's lunch a proper home. Containers for meals worth looking forward to.

Taste it
Vegetable Prep & Salad Spinners

Salad spinners and vegetable-prep tools for everyday salads, bowls, and side dishes. A little less kitchen setup, a little more time to enjoy the meal.

Taste it
Blenders & Smoothie Tools

Blenders for fruit, yogurt, soups, and the combinations you actually enjoy. Everyday kitchen tools, not a promise in a glass.

Taste it
Sheet Pans & Roasting Essentials

Sheet pans and roasting racks for vegetables and simple oven meals. Useful equipment for dinner without an elaborate production.

Taste it

Sponsorship complete. Dine on...

Across our publications

In Other News

Latest stories from other publications.

Explore all publications (opens in a new tab)